AFM
HSTO

Anson Funds Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Anson Funds Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-207
Closed -$119K – 91
2015
Q4 		$119K Buy
+207
New +$145K 0.04% 83

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Anson Funds Management's HSTO Position: Q1 2016 in Review

Anson Funds Management sold out of Histogen Inc. Common Stock (HSTO) in Q1 2016, closing a stake of 207 shares — an estimated $119K sold.

Anson Funds Management first reported a position in HSTO in Q4 2015 and held it in 1 quarter. The position peaked at $119K in Q4 2015. 32 funds tracked by Wall St. Rank hold HSTO as of Q1 2016.

  • Anson Funds Management reported no remaining Histogen Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Anson Funds Management sold 207 Histogen Inc. Common Stock shares in Q1 2016, an estimated $119K.
  • Anson Funds Management first reported a position in Histogen Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • Anson Funds Management's Histogen Inc. Common Stock position peaked at $119K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2016.

Based on Anson Funds Management's 13F filing for Q1 2016, filed 13 May 2016.